Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06358274 · ClinicalTrials.gov registry record

Nutritional and Metabolic Dynamics of Thru-Hiking: A Longitudinal Study on the Colorado Trail

A clinical trial, sponsored by University of Minnesota.

Completed
Registry status
15
Enrollment target

NCT06358274: Completed study, sponsored by University of Minnesota.

NCT06358274 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06358274 has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
15 participants
Enrollment target

Study Summary

Thru-hiking the Colorado Trail presents distinct challenges owing to its diverse landscapes and high altitudes. The study aims to delve into the physiological and nutritional facets of extended wilderness trekking among thru-hikers. Activities encompass participant recruitment from the Colorado Trail Foundation community, baseline and post-trail assessments including blood lipid panel analysis and anthropometric measurements, data collection during the trail period involving recording daily mileage, exertion levels, and dietary intake, rigorous statistical analysis to explore correlations among various parameters, and adherence to ethical considerations including obtaining formal approval and ensuring informed consent procedures are followed to safeguard participants' rights and privacy. Through this endeavor, the study seeks to offer insights into the metabolic responses and cardiovascular implications associated with thru-hiking, shedding light on the interplay between diet, lifestyle factors, and metabolic health in challenging environments. The specific aims include examining the metabolic responses and cardiovascular implications associated with thru-hiking, exploring correlations between dietary intake and blood lipid profiles, and elucidating the interplay between lifestyle factors and metabolic health in demanding environments. This study is not limited to program evaluation, quality assurance, or improvement activities within a specific department or setting but rather seeks to contribute to scientific knowledge and inform evidence-based recommendations for individuals engaging in thru-hiking or similar high-intensity activities.

Primary Outcome

changes in total cholesterol levels from baseline to within 2 days of completing the Colorado Trail.

Interventions

  • OTHER Thru-hiking

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-05-01
Est. Completion 2024-12-01
University of Minnesota

966 total trials

What the finished NCT06358274 record still lists

NCT06358274 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Thru-hiking is the first listed.

NCT06358274 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06358274 about?

NCT06358274 is a clinical study titled "Nutritional and Metabolic Dynamics of Thru-Hiking: A Longitudinal Study on the Colorado Trail". Thru-hiking the Colorado Trail presents distinct challenges owing to its diverse landscapes and high altitudes. The study aims to delve into the physiological and nutritional facets of extended wilderness trekking among thru-hikers. Activities encompass participant recruitment from the Colorado Trai...

What is the current status of trial NCT06358274?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2024-05-01. Estimated completion is 2024-12-01.

What interventions are being tested in trial NCT06358274?

The interventions under investigation include: Thru-hiking (OTHER).

Who is sponsoring clinical trial NCT06358274?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06358274, the US trial registry maintained by the National Library of Medicine. NCT06358274 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.